BB Biotech says it had to weather the storm last year
BB Biotech managed to “weather the storm” that gripped the biotech sector in 2016 and beat its benchmark index, according to its latest annual report.
BB Biotech AG
-
-
Biotech in the fight against cancer
Big players in the healthcare sector are desperate to differentiate their approved ‘checkpoint inhibitors’ (a drug that unleashes an immune system attack on cancer cells) by combining their use with conventional chemotherapy or other new drugs. Biotechnology firms are developing many of these next-generation combination agents as well as continuing to strengthen their positions in…
-
Volatility presents opportunities in biotech – BB Biotech
The recent sell-off in global stock markets has presented attractive takeover opportunities in the biotech sector, according to BB Biotech AG.
